Gian Franco Piredda1,2,3, Piotr Radojewski4,5, Arun Joseph5,6,7, Gabriele Bonanno5,6,7, Karl Egger8, Shan Yang8, Punith B. Venkategowda9, Ricardo A. Corredor-Jerez1,2,3, Bénédicte Maréchal1,2,3, Roland Wiest4,5, Jean-Philippe Thiran2,3, Tom Hilbert1,2,3, and Tobias Kober1,2,3
1Advanced Clinical Imaging Technology, Siemens Healthcare AG, Lausanne, Switzerland, 2Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 3LTS5, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, 4Support Center for Advanced Neuroimaging, Institute for Diagnostic and Interventional Neuroradiology, Inselspital, Bern University, Bern, Switzerland, 5Translational Imaging Center, sitem-insel AG, Bern, Switzerland, 6Advanced Clinical Imaging Technology, Siemens Healthcare AG, Bern, Switzerland, 7Magnetic Resonance Methodology, Institute of Diagnostic and Interventional Neuroradiology, University of Bern, Bern, Switzerland, 8Department of Neuroradiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 9Siemens Healthcare Pvt. Ltd., Bangalore, India
Synopsis
Previous studies at 3T have shown that T1
relaxometry enables personalized characterization of brain tissues by comparing
physical properties of a single patient to a normative atlas. Ultra-high field
imaging allows exploiting this concept at even higher resolutions, which can be
crucial to detect certain diseases. To this end, here we established an atlas
of normative T1 values at 7T from acquisitions with 0.6$$$\times$$$0.6$$$\times$$$0.6 mm3 isotropic resolution. Additionally, the
clinical potential and improvement of 7T vs. 3T imaging is shown in two case
reports from patients scanned at both field strengths.
Introduction
The hardware independency and
improved reproducibility of quantitative MRI in comparison to conventional imaging
enables the comparison of physical tissue properties to normal values in a
single patient1–3. In multiple sclerosis (MS), for
example, previous studies at 3T have shown that relaxation time deviations from
normative atlases are more strongly correlated with disability than
conventional MRI-based metrics4–6. Notably, in some diseases, it is
essential to detect small focal abnormalities (e.g., in epilepsy). The
improved SNR at 7T enables higher resolutions and can thus add clinical value
in this context. As relaxation times change across field strengths, new
field-strength-specific atlases of normative values are needed.
In this study, we establish an
atlas of normative T1 values at 7T with 0.6$$$\times$$$0.6$$$\times$$$0.6 mm3 isotropic resolution.
Example deviation maps are evaluated in two patients scanned both at 3T and 7T;
in a case study setting, resulting T1 deviations from the respective normative atlases are compared between field strengths.Methods
Study population and MR protocolTwo separate healthy cohorts underwent MR
examination at different field strengths:
- 3T
(MAGNETOM Prisma, Siemens Healthcare, Erlangen, Germany): 201 subjects (123
females, median age = 31 y/o, range = [20-64] y/o);
- 7T
(MAGNETOM Terra, Siemens Healthcare, Erlangen, Germany): 19 subjects (11
females, median age = 28 y/o, range = [15-72] y/o).
The MP2RAGE sequence was used for T
1
mapping
7 employing the protocol parameters reported
in Table 1. Prior to each examination, written informed consent was obtained.
Additionally, a patient with epilepsy (female,
25 y/o) and one with MS (male, 50 y/o) were scanned with the MP2RAGE sequence
at both field strengths, in agreement with the institutional regulations.
Image processing
The MP2RAGE UNI images were skull-stripped
and white matter (WM) a posteriori probability maps were estimated using the prototype software MorphoBox
8, whose pipeline was adapted to reliably
segment brain tissues from UNI images at 7T
9. A separate study-specific template (SST) was
built for the two healthy cohorts using the Advanced Normalization Tools (ANTs)
10,11. Skull-stripped UNI images of the healthy
subjects were then spatially registered onto the respective SST, and the
estimated transformation was applied to the T
1 maps and WM probability
maps.
Normative atlases
In the SST space, an atlas of reference T
1
values in healthy tissues was established by modeling the T
1 inter-subject
variability with age and sex: $$\mathit{E}\left\{T_{1}\right\}=\ {\beta}_0+\beta_{sex}\ast sex+\beta_{age}\ast age+\beta_{{age}^2}\ast{age}^2$$ with $$$\beta_{0}$$$ being the model intercept, sex = 1 if the
subject is male, 0 if female. At 3T, the age was centered at the mean age of the
healthy cohort (35 y) and root mean squared errors (RMSE) were evaluated as an
estimation of the standard deviation (SD) of the residuals error across the
linear model. At 7T, given the small size of the healthy cohort and the sparse
coverage of the age range, a simple average and SD were considered for the
atlas modelling.
A WM prior was computed in both SST spaces by
averaging the spatially normalized WM probability maps of the healthy subjects
and used to restrict our analysis to WM voxels to mitigate the amount of false‐positives in the brain cortex
3.
Single-subject comparison
To investigate the advantage of
single-subject comparison at 7T, deviations from established atlases were calculated voxel-wise and expressed in z-score maps in the two case reports
scanned at both field strengths.
Results
Example slices of the established T1
atlases are shown in Figure 1. To illustrate the expected relaxation times, average
T1 values in WM were found to be: E{T1,3T} ± RMSE3T
= 815 ± 42 ms, E{T1,7T} ± SD7T = 1203 ± 60 ms. A
similar coefficient of variation (COV) was thus observed at 3T and 7T, respectively
5.1% and 5.0%.
Z-score maps evaluated in the two patients
are displayed in Figure 2 and Figure 3. In the epileptic patient, 7T MRI
allowed to better delineate the potential epileptogenic
structural lesion and the surrounding alteration of myelination in
the occipital lobe, which were detected by the proposed single-subject comparison
at both field strengths (zT1,3T = 4.27 ± 1.14; zT1,7T =
4.96 ± 2.06), but with increased conspicuity at 7T (see Figure 2). In the MS
patient, T1 alterations were automatically detected by the proposed
method, with small focal changes being better delineated at 7T, as shown in
Figure 3. Discussion and Conclusion
In this work, we established an atlas of normative T1 values
at 7T for the personalized detection and characterization of brain T1
alterations. Despite the small
sample size, the atlas proved valuable in revealing tissue deviations from the
normative atlases in single‐subject comparisons, showing greater detail compared to the 3T atlas. Future
work should focus on expanding the enrolled healthy cohort to cover the whole adult
age range and better model T1 variations with age. Additionally,
these preliminary results should be validated in larger cohorts. However,
the similar COV observed between the atlases at 3T and 7T, makes already the
new atlas a promising tool for the detection of subtle alterations that are
not visible in conventional MR, as previously shown at 3T3,4, but at higher resolution.Acknowledgements
No acknowledgement found.References
1. Warntjes
JBM, Engström M, Tisell A, Lundberg P. Brain Characterization Using Normalized
Quantitative Magnetic Resonance Imaging. PLoS One. 2013;8(8).
doi:10.1371/journal.pone.0070864
2. Bonnier G,
Fischi-Gomez E, Roche A, et al. Personalized pathology maps to quantify diffuse
and focal brain damage. NeuroImage Clin. 2019;21:101607. doi:10.1016/j.nicl.2018.11.017
3. Piredda GF, Hilbert T, Granziera C, et al. Quantitative brain
relaxation atlases for personalized detection and characterization of brain
pathology. Magn Reson Med. 2020;83(1):337-351. doi:10.1002/mrm.27927
4. Piredda
GF, Hilbert T, Vaneckova M, et al. Periventricular gradients of brain pathology
in early and progressive MS revealed by qMRI. In: Proceedings of the
International Society of Magnetic Resonance in Medicine. 2021. Abstract number: 2795.
5. Ravano V, Piredda GF, Vaneckova M, et al. T1 abnormalities in
atlas-based white matter tracts: reducing the clinico-radiological paradox in
multiple sclerosis using qMRI. In: Proceedings of the
International Society of Magnetic Resonance in Medicine. 2021. Abstract number: 2796.
6. Piredda GF, Hilbert T, Vaneckova M, et al. Quantitative T1 deviations
in brain lesions and NAWM improve the clinico-radiological correlation in early MS. In: MULTIPLE SCLEROSIS JOURNAL. Vol 26. SAGE PUBLICATIONS LTD 1
OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND; 2020:418.
7. Marques
JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele P-F, Gruetter R.
MP2RAGE, a self bias-field corrected sequence for improved segmentation and
T1-mapping at high field. Neuroimage. 2010;49(2):1271-1281. doi:10.1016/j.neuroimage.2009.10.002
8. Schmitter D, Roche A, Maréchal B, et al. An evaluation of
volume-based morphometry for prediction of mild cognitive impairment and
Alzheimer’s disease. NeuroImage Clin. 2015;7:7-17.
doi:10.1016/j.nicl.2014.11.001
9. Piredda
GF, Venkategowda PB, Radojewski P, et al. Automated brain morphometry for
sub-millimeter 7T MRI using transfer learning. Submitted in Parallel to
ISMRM 2022.
10. Avants BB,
Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of
ANTs similarity metric performance in brain image registration. Neuroimage.
2011;54(3):2033-2044.
11. Avants BB,
Yushkevich P, Pluta J, et al. The optimal template effect in hippocampus
studies of diseased populations. Neuroimage. 2010;49(3):2457-2466.